People

Andrea Testa

Andrea Testa is TRIMTECH vice president of chemistry and a scientific co-founder of Amphista Therapeutics. His targeted-protein-degradation experience includes work in Alessio Ciulli’s Dundee laboratory and developing oral, brain-penetrant degraders at Amphista. He holds an Aberdeen doctorate and a Milan chemistry master’s.